Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Pharma
FTC to review Novo Holdings' Catalent buyout for another month
Despite a new 30-day extension on the FTC's review of Novo Holdings' Catalent buyout, the CDMO giant still expects the deal to close by year-end 2024.
Fraiser Kansteiner
May 3, 2024 2:00pm
FTC to review Novo Holdings' Catalent buyout for 30 more days
Apr 8, 2024 11:58am
Catalent reorg leaves 300 without jobs as CDMO awaits buyout
Feb 15, 2024 8:45am
Catalent's Indiana filling plant in hot water with the FDA again
Feb 7, 2024 2:11pm
Novo Holdings pays $16.5B to scoop up CDMO giant Catalent
Feb 5, 2024 10:22am
Xellia to axe 80 positions at Ohio plant previously owned by BI
Dec 13, 2023 9:19am